Guiding patients with type 2 diabetes (T2D) toward the most appropriate bariatric and
metabolic procedure is crucial for improving outcomes. In recent years, Roux-en-Y gastric …

Background The prevalence of smoking among patients undergoing bariatric surgery has
been reported to be as high as 40%. The effect of smoking in the perioperative period has …

Background Marginal ulcerations (MU) are a common and concerning complication
following Roux-en-Y gastric bypass (RYGB) surgery. The aim of the present study was to …

Background Smoking has been associated with postoperative complications and mortality in
bariatric surgery. The evidence for smoking is based on self-report and medical charts …

Background Marginal ulcer (MU) formation is a known problem after gastric bypass. The
Metabolic and Bariatric Surgery Accreditation and Quality Improvement Program (MBSAQIP) …

Background The use of nonsteroidal anti-inflammatory drugs (NSAIDs) is discouraged after
bariatric surgery. The effect of NSAIDs on patients who have undergone sleeve gastrectomy …

Background There are several ways to perform the gastrojejunostomy (GJ) anastomosis in
laparoscopic Roux-en-Y gastric bypass (LRYGB). Surgeons typically use a variation of three …

Background Marginal ulcer (MU) formation is a serious complication following Roux-en-Y
Gastric Bypass (RYGB). Incidental data suggested a higher incidence of MU following …

Marginal ulcer (MU) is a potential complication following Roux-en-Y gastric bypass (RYGB),
with a mean prevalence of 4.6%. Early identification and prompt intervention are crucial to …

Roux-en-Y gastric bypass (RYGB)-associated marginal ulceration (MU) poses significant
challenges for both patients and clinicians. Persistent symptoms such as epigastric pain …